De Angelis I - Search Results

1

The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics.

Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. Sambuy Y, et al. Among authors: de angelis i. Cell Biol Toxicol. 2005 Jan;21(1):1-26. doi: 10.1007/s10565-005-0085-6. Cell Biol Toxicol. 2005. PMID: 15868485 Review.

2

Formation of organoid structures and extracellular matrix production in an intestinal epithelial cell line during long-term in vitro culture.

Sambuy Y, De Angelis I. Sambuy Y, et al. Among authors: de angelis i. Cell Differ. 1986 Sep;19(2):139-47. doi: 10.1016/0045-6039(86)90071-0. Cell Differ. 1986. PMID: 3757038

3

Cytotoxic effects of wheat gliadin-derived peptides.

Paganuzzi AS, Zucco F, Cardelli M, de Angelis I, Mattei R, Pino A, Rocca E, Zampaglioni F. Paganuzzi AS, et al. Among authors: de angelis i. Toxicology. 1985 Dec;37(3-4):225-32. doi: 10.1016/0300-483x(85)90085-x. Toxicology. 1985. PMID: 4071551

4

Established cell lines for safety assessment of food contaminants: differing furazolidone toxicity to V 79, HEp-2 and Caco-2 cells.

De Angelis I, Hoogenboom LA, Huveneers-Oorsprong MB, Zucco F, Stammati A. De Angelis I, et al. Food Chem Toxicol. 1994 May;32(5):481-8. doi: 10.1016/0278-6915(94)90046-9. Food Chem Toxicol. 1994. PMID: 8206447

5

N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.

Rossi L, De Angelis I, Pedersen JZ, Marchese E, Stammati A, Rotilio G, Zucco F. Rossi L, et al. Among authors: de angelis i. Mol Pharmacol. 1996 Mar;49(3):547-55. Mol Pharmacol. 1996. PMID: 8643095

6

In vitro toxicity and formation of early conjugates in Caco-2 cell line treated with clenbuterol, salbutamol and isoxsuprine.

Stammati A, Badino P, De Angelis I, Re G, Vincentini O, Zanetti C, Zucco F, Brambilla G. Stammati A, et al. Among authors: de angelis i. Eur J Drug Metab Pharmacokinet. 1997 Apr-Jun;22(2):173-8. doi: 10.1007/BF03189802. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9248787

7

Characterization of furazolidone apical-related effects to human polarized intestinal cells.

De Angelis I, Vincentini O, Brambilla G, Stammati A, Zucco F. De Angelis I, et al. Toxicol Appl Pharmacol. 1998 Sep;152(1):119-27. doi: 10.1006/taap.1998.8445. Toxicol Appl Pharmacol. 1998. PMID: 9772207

8

A contribution to safety assessment of veterinary drug residues: in vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues.

Klee S, Baumung I, Kluge K, Ungemach FR, Horne E, O'Keeffe M, De Angelis I, Vignoli AL, Zucco F, Stammati A. Klee S, et al. Among authors: de angelis i. Xenobiotica. 1999 Jun;29(6):641-54. doi: 10.1080/004982599238452. Xenobiotica. 1999. PMID: 10426562

9

Metabolism of furazolidone: alternative pathways and modes of toxicity in different cell lines.

De Angelis I, Rossi L, Pedersen JZ, Vignoli AL, Vincentini O, Hoogenboom LA, Polman TH, Stammati A, Zucco F. De Angelis I, et al. Xenobiotica. 1999 Nov;29(11):1157-69. doi: 10.1080/004982599238029. Xenobiotica. 1999. PMID: 10598749

10

Apoptosis evaluation in epithelial cells exposed to different chemicals: relevance of floating cells.

Turco L, De Angelis I, Stammati A, Zucco F. Turco L, et al. Among authors: de angelis i. Cell Biol Toxicol. 2000;16(1):53-62. doi: 10.1023/a:1007696604725. Cell Biol Toxicol. 2000. PMID: 10890506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters